Vaxigrip

BIOLOGICAL7 trials

Conditions

Acute Coronary Syndromes (ACS)COPD (Chronic Obstructive Pulmonary Disease)Elderly InfectionInfluenzaInfluenza VaccineInfluenza, HumanObesityPneumonia

Phase 2

Clinical Study in Children, 6 Months to 3 Years of Age, to Assess Two Dose Levels of an Experimental Flu Vaccine, Using a Licensed Influenza Virus Vaccine, Vaxigrip® as the Control

CompletedNCT00778895

GlaxoSmithKlineInfluenza

Start: 2008-11-10End: 2009-08-19Updated: 2018-08-17

Immunogenicity and Safety Study of Allantoic Split Inactivated Seasonal Influenza Vaccine (VSI)

CompletedNCT03016143

Research Institute for Biological Safety ProblemsInfluenza

Start: 2016-10-31End: 2016-12-31Updated: 2018-06-07

Phase 3

Analysis of Growth Differentiation Factor 15 (GDF-15), Mid Regional proAdrenomedullin (MR proADM), and Persepsin Levels in Patient in Acute Coronary Syndrome Patients With Pneumonia, With or Without Influenza Vaccination

RecruitingNCT07604103

University of BrawijayaAcute Coronary Syndromes (ACS), COPD (Chronic Obstructive Pulmonary Disease), Pneumonia

Start: 2026-01-01End: 2026-10-10Target: 60Updated: 2026-05-22

Phase 4

Comparison of 4 Influenza Vaccines in Seniors

CompletedNCT01368796

University of British ColumbiaInfluenza Vaccine

Start: 2011-07-31End: 2012-05-31Updated: 2015-04-15

A Time-motion Study Comparing Self- to Nurse-vaccination With Influenza Vaccine

CompletedNCT01665807

Brenda ColemanInfluenza, Vaccination Site Reactions (HT)

Start: 2012-09-30End: 2012-12-31Updated: 2017-04-19

Safety and Efficacy of Intradermal Trivalent Influenza Vaccination in Institutionalized Older Adults

NCT01967368

The University of Hong KongInfluenza, Human

Start: 2013-10-31End: 2015-06-30Target: 100Updated: 2013-10-22

Effectiveness and Tolerability of Influenza Vaccine in Patients at Risk for Severe and Complicated Influenza

Active, not recruitingNCT06286488

Medical University of WarsawElderly Infection, Influenza, Obesity +4

Start: 2020-09-15End: 2026-05-01Updated: 2024-03-01

Related Papers

Safety and immunogenicity of trivalent inactivated influenza vaccine in adults 60 years of age and older: a phase II, a randomized, comparative trial in Kazakhstan.

2020-02-122 citations

Differences in efficiency, satisfaction and adverse events between self-administered intradermal and nurse-administered intramuscular influenza vaccines in hospital workers.

2015-10-319 citations

Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v).

2012-08-0763 citations

Immunogenicity and Safety of 2 Dose Levels of a Thimerosal-Free Trivalent Seasonal Influenza Vaccine in Children Aged 6-35 Months: A Randomized, Controlled Trial.

2012-03-0128 citations